KCTD11 Tumor Suppressor Gene Expression Is Reduced in Prostate Adenocarcinoma
Figure 1
KCTD11 loss of heterozygosity (LOH) analysis in prostate cancer samples matched with paired normal tissues. (a) Schematic representation of human KCTD11 locus. D17S960 microsatellite marker position is shown. (b) KCTD11 LOH frequency in prostate adenocarcinoma samples (D17S960, specific microsatellite marker, D4S174, background marker). (c) Representative images of KCTD11 LOH in prostate adenocarcinoma (N normal tissues, T tumoral tissue, and M metastasis).
